PDS Planning Inc Buys 58 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

PDS Planning Inc grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,343 shares of the medical equipment provider’s stock after acquiring an additional 58 shares during the quarter. PDS Planning Inc’s holdings in Intuitive Surgical were worth $453,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the business. Liberty Capital Management Inc. boosted its position in Intuitive Surgical by 3.8% in the fourth quarter. Liberty Capital Management Inc. now owns 815 shares of the medical equipment provider’s stock worth $275,000 after purchasing an additional 30 shares during the last quarter. Miracle Mile Advisors LLC boosted its position in Intuitive Surgical by 2.3% in the fourth quarter. Miracle Mile Advisors LLC now owns 1,438 shares of the medical equipment provider’s stock worth $485,000 after purchasing an additional 32 shares during the last quarter. Ausdal Financial Partners Inc. boosted its position in Intuitive Surgical by 1.5% in the fourth quarter. Ausdal Financial Partners Inc. now owns 2,192 shares of the medical equipment provider’s stock worth $739,000 after purchasing an additional 33 shares during the last quarter. Venturi Wealth Management LLC boosted its position in Intuitive Surgical by 10.7% in the fourth quarter. Venturi Wealth Management LLC now owns 341 shares of the medical equipment provider’s stock worth $115,000 after purchasing an additional 33 shares during the last quarter. Finally, Modera Wealth Management LLC boosted its position in Intuitive Surgical by 2.0% in the third quarter. Modera Wealth Management LLC now owns 1,715 shares of the medical equipment provider’s stock worth $501,000 after purchasing an additional 34 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

ISRG stock traded up $8.22 during trading on Tuesday, hitting $377.15. 524,051 shares of the company’s stock traded hands, compared to its average volume of 1,659,334. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $403.76. The business has a fifty day simple moving average of $386.57 and a 200 day simple moving average of $344.41. The stock has a market capitalization of $133.68 billion, a price-to-earnings ratio of 66.59, a P/E/G ratio of 5.69 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating the consensus estimate of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. Intuitive Surgical’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same quarter last year, the business earned $1.00 earnings per share. Research analysts forecast that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 196 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00. Following the transaction, the senior vice president now owns 1,842 shares of the company’s stock, valued at approximately $736,800. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Intuitive Surgical news, SVP Mark Brosius sold 196 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00. Following the transaction, the senior vice president now owns 1,842 shares of the company’s stock, valued at approximately $736,800. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Fredrik Widman sold 5,041 shares of the firm’s stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $397.07, for a total transaction of $2,001,629.87. Following the transaction, the vice president now directly owns 110 shares in the company, valued at approximately $43,677.70. The disclosure for this sale can be found here. In the last quarter, insiders have sold 248,418 shares of company stock valued at $95,927,097. Company insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of analyst reports. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research report on Friday, January 19th. Royal Bank of Canada lifted their price objective on Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a research report on Wednesday, January 24th. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, April 8th. Truist Financial lifted their price objective on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Finally, Robert W. Baird lowered their price objective on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research report on Friday. Five investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $396.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.